在口腔膜状细胞癌的性别特异性生存和治疗延迟
Sandhya Kalavacherla1, Solene Poulhazan2, Emily Funk1,3
1Department of Otolaryngology-Head and Neck Surgery, UC San Diego Health, La Jolla, California, USA.
概括
女性口腔支状细胞癌 (OPSCC) 患者的生存率较差,特别是HPV阴性疾病患者. 这些妇女的治疗延迟更为常见,并且与更糟糕的结果有关,这表明潜在的系统性问题.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 头部和部癌症 头部和部癌症
背景情况:
- 口腔支状细胞癌 (OPSCC) 主要影响男性,使女性的结果受到研究不足.
- 了解性别特异性因素对于改善女性OPSCC患者的预后至关重要.
研究的目的:
- 确定影响口腔状细胞癌 (OPSCC) 结果的性别特定因素.
- 为了完善诊断OPSCC的女性患者的预后.
主要方法:
- 来自国家癌症数据库 (2004-2019) 的192,973例OPSCC病例的回顾性队列分析.
- 性别之间的社会人口统计学,临床和治疗特征的比较.
- 多变量回归模型分析存活率,治疗延迟以及它们对结果的影响.
主要成果:
- 女性 (19%) 呈现的疾病进展较慢,但生存率较差,特别是在人类乳头瘤病毒 (HPV) 阴性OPSCC (HR=1.11).
- 女性更有可能在治疗开始 (OR=1.04) 和辅助放射治疗 (OR=1.11) 中出现延迟.
- 超过60天的治疗延迟 (HR=1.17) 和辅助治疗延迟 (HR=1.24) 与女性的生存率较差有关.
结论:
- 女性OPSCC患者的生存率低于男性,特别是在HPV阴性病例中,尽管在早期阶段呈现.
- 治疗延迟,特别是辅助放射治疗,在女性中更为普遍,并显著恶化了生存率.
- 导致治疗延迟的系统因素可能是OPSCC妇女观察到的预后较差的原因.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.7K
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
